Delcath Systems Inc (DCTH)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $714.89M
Last updated: Nov 17, 2026 at 11:03 AM ET
Delcath Systems Inc (DCTH) Stock Forecast
Analysts expect Delcath Systems (DCTH) to earn $0.20 per share in the fiscal year ending Dec 31, 2026, on revenue of $116.48M. Of 5 analysts, 5 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 5 ratings average 1.80, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 20.0% |
| Buy | 4 | 80.0% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 5
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 35.0% and revenue estimates rise 20.1%.
- Fiscal year ending Dec 31, 2026
- $0.20
- EPS consensus, revenue $116.48M
- Fiscal year ending Dec 31, 2027
- $0.27
- EPS consensus, revenue $139.91M
- Next report
- Feb 22, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.20 | $0.20 to $0.20 | 1 | $116.48M | $115.48M to $117.00M | 5 |
| Dec 31, 2027 | $0.27 | $0.12 to $0.51 | 4 | $139.91M | $129.52M to $146.80M | 5 |
Quarterly Estimates
The EPS consensus rises from -$0.11 for the quarter ending Dec 31, 2026 to -$0.01 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.11 | -$0.18 to -$0.02 | 8 | $27.60M | $25.73M to $28.98M | 8 |
| Mar 31, 2027 | -$0.01 | -$0.01 to -$0.01 | 1 | $32.20M | $31.90M to $32.50M | 2 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 0 upward and 2 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 1 |
| Fiscal year ending Dec 31, 2027 | 0 | 1 |
| Quarter ending Mar 31, 2027 | 0 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has turned from a loss of $0.14 to a profit.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $0.20 | -$0.15 | -$0.14 | -$0.14 | -$0.14 | N/A |
| Fiscal year ending Dec 31, 2027 | $0.27 | $0.04 | $0.05 | $0.05 | $0.05 | +505.6% |
| Quarter ending Mar 31, 2027 | -$0.01 | -$0.04 | -$0.04 | -$0.04 | $0.06 | N/A |
Frequently Asked Questions About DCTH
What is the DCTH stock forecast?
Consensus analyst estimates put Delcath Systems's EPS at $0.20 for the fiscal year ending Dec 31, 2026, on revenue of $116.48M. The consensus rating from 5 analysts is Buy.
How do analysts rate DCTH stock?
Of 5 analysts covering Delcath Systems, 1 rates it Strong Buy, 4 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from DCTH next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.20, with estimates from $0.20 to $0.20 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $0.27, with estimates from $0.12 to $0.51 from 4 analysts.
What revenue do analysts expect from Delcath Systems next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $116.48M, with estimates from $115.48M to $117.00M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $139.91M, with estimates from $129.52M to $146.80M.
How many analysts cover DCTH?
5 analysts rate Delcath Systems stock, and 1 analyst estimates its EPS for the fiscal year ending Dec 31, 2026.
DCTH pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors